Literature DB >> 16001653

Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.

Saburo Fukuda1, Toshiyuki Itamoto, Hideki Nakahara, Toshihiko Kohashi, Hideki Ohdan, Hiroshi Hino, Makoto Ochi, Hirotaka Tashiro, Toshimasa Asahara.   

Abstract

BACKGROUND/AIMS: Solitary small-sized HCCs tend to be considered as less aggressive cancer, and non-surgical treatments have recently been preferred. The aim of this study was to clarify the clinicopathological features and the prognostic factors of small-sized HCCs and to evaluate the significance of hepatic resection for them.
METHODOLOGY: Eighty patients with HCC up to 2cm in diameter who had undergone hepatic resection were enrolled in this study. We investigated the clinicopathological features and evaluated the prognostic factors by univariate and multivariate analyses.
RESULTS: The overall survival rates at 3, 5 and 10 years were 83%, 69% and 36%, respectively, and the corresponding disease-free survival rates were 63%, 41% and 10%. Well-differentiated, moderately differentiated and poorly differentiated HCC were detected in 29%, 65% and 6% of the patients, respectively. Furthermore, microscopic portal vein invasion (vp), hepatic vein invasion (vv) and intrahepatic metastasis (im) were positive in 15%, 4% and 10% of the patients, respectively. Multivariate analysis revealed that Child-Pugh classification (p=0.005) and vp (p=0.0008) were independent prognostic factors for survival rate and that platelet count (p=0.002) and tumor differentiation (p=0.0016) were independent prognostic factors for disease-free survival rate.
CONCLUSIONS: Even solitary small-sized (up to 2cm in diameter) HCC already have the characteristics of advanced HCC. When hepatic function is well preserved, hepatic resection should be the first choice for local control, especially in cases of moderately to poorly differentiated HCC, because the frequency of microscopic vascular invasion is high.

Entities:  

Mesh:

Year:  2005        PMID: 16001653

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  22 in total

1.  Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.

Authors:  Takanori Sakaguchi; Shohachi Suzuki; Yoshifumi Morita; Kousuke Oishi; Atsushi Suzuki; Kazuhiko Fukumoto; Keisuke Inaba; Satoshi Nakamura; Hiroyuki Konno
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

Review 2.  miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Angela M Liu; Wei Wang; John M Luk
Journal:  Hepat Oncol       Date:  2014-09-09

3.  Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Authors:  Shotaro Enomoto; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2011-01-09       Impact factor: 6.047

5.  Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.

Authors:  Li Jiang; Xue Li; Qi Cheng; Bin-Hao Zhang
Journal:  Tumour Biol       Date:  2015-04-17

6.  Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study.

Authors:  Q Li; J Wang; Y Sun; Y L Cui; J T Juzi; H X Li; B Y Qian; X S Hao
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

7.  Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Authors:  J Qi; J Wang; H Katayama; S Sen; S M Liu
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

8.  Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.

Authors:  Ken Shirabe; Kiyoshi Kajiyama; Norifumi Harimoto; Hideaki Masumoto; Tatsuro Fukuya; Masafumi Ooya; Yoshihiko Maehara
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

9.  Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Authors:  Kosaku Moribata; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Tatsuya Shiraki; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Masao Ichinose
Journal:  World J Hepatol       Date:  2012-12-27

10.  Diagnostic value of circulating microRNAs for hepatocellular carcinoma.

Authors:  Yanping Yang; Rui Zhu
Journal:  Mol Biol Rep       Date:  2014-07-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.